NCT05822622

Brief Summary

The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

April 29, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

2 months

First QC Date

March 26, 2023

Last Update Submit

April 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • collection of results of echocardiography (those detect HFpEF) with abdominal ultrasound and transient elastography results (those detect NAFLD) and find relationship between the results.

    looking for relationship between echocardiographic findings (that detect heart failure with preserved ejection fraction) and finding in abdominal ultrasound and transient elastography (detection of nonalcoholic fatty liver disease) to detect the relationship between those two diseases.

    up to 28 weeks.

Study Arms (2)

HFpEF(heart failure with preserved ejection fraction)

chronic heart failure with echocardiographic finding of LVEF (left ventricular ejection fraction) equal or more than 50% , diagnostic test :Abdominal ultrasound and transient elastography for detecting non alcoholic fatty liver disease .

Other: echocardiography

NAFLD(non alcoholic fatty liver disease)

ultrasound and transient elastographic finding of fatty liver disease, diagnostic test :echocardiography to determine heart failure with preserved ejection fraction .

Other: echocardiography

Interventions

to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease

Also known as: abdominal ultrasound and transient elastography
HFpEF(heart failure with preserved ejection fraction)NAFLD(non alcoholic fatty liver disease)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients presented by heart failure with preserved ejection fraction and those with fatty liver disease

You may qualify if:

  • clinical diagnosis of nonalcoholic fatty liver disease. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Asmaa elsayed khalifa

Sohag, El Monshah, 82515, Egypt

Location

Asmaa E khalifa

Sohag, 82515, Egypt

Location

Related Publications (1)

  • Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7-11. doi: 10.15420/cfr.2016:25:2.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Study Officials

  • Aml K Ahmed, A professor

    Sohag University

    STUDY CHAIR
  • Alshimaa L Hamed, lecturer

    Sohag University

    STUDY CHAIR

Central Study Contacts

Asmaa E khalifa, resident

CONTACT

Usama A Arafa, professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
5 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident of internal medicine

Study Record Dates

First Submitted

March 26, 2023

First Posted

April 21, 2023

Study Start

April 29, 2023

Primary Completion

July 1, 2023

Study Completion

August 30, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Locations